A general form of covariate adjustment in clinical trials under covariate-adaptive randomization
- PMID: 40677930
- PMCID: PMC12264724
- DOI: 10.1093/biomet/asaf029
A general form of covariate adjustment in clinical trials under covariate-adaptive randomization
Abstract
In randomized clinical trials, adjusting for baseline covariates can improve credibility and efficiency for demonstrating and quantifying treatment effects. This article studies the augmented inverse propensity weighted estimator, which is a general form of covariate adjustment that uses linear, generalized linear and nonparametric or machine learning models for the conditional mean of the response given covariates. Under covariate-adaptive randomization, we establish general theorems that show a complete picture of the asymptotic normality, efficiency gain and applicability of augmented inverse propensity weighted estimators. In particular, we provide for the first time a rigorous theoretical justification of using machine learning methods with cross-fitting for dependent data under covariate-adaptive randomization. Based on the general theorems, we offer insights on the conditions for guaranteed efficiency gain and universal applicability under different randomization schemes, which also motivate a joint calibration strategy using some constructed covariates after applying augmented inverse propensity weighted estimators.
Keywords: Augmentation; Covariate-adaptive randomization; G-computation; Model-assisted inference; Multiple treatment arms; Nonlinear adjustment.
© The Author(s) 2025. Published by Oxford University Press on behalf of Biometrika Trust. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
References
-
- Baldi Antognini A. & Zagoraiou M. (2015). On the almost sure convergence of adaptive allocation procedures. Bernoulli 21, 881–908.
-
- Chernozhukov V., Chetverikov D., Demirer M., Duflo E., Hansen C. & Newey W. (2017). Double/debiased/Neyman machine learning of treatment effects. Am. Econ. Rev. 107, 261–5.
-
- Cohen P. L. & Fogarty C. B. (2023). No-harm calibration for generalized Oaxaca–Blinder estimators. Biometrika 111, 331–8.
-
- Davies M. J., Russell-Jones D., Selam J.-L., Bailey T. S., Kerényi Z., Luo J., Bue-Valleskey J., Iványi T., Hartman M. L., Jacobson J. G. & Jacober S. J. (2016). Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: Imagine 2 randomized trial. Diabetes Obes. Metab. 18, 1055–64. - PMC - PubMed
-
- EMA (2015). Guideline on adjustment for baseline covariates in clinical trials. London, UK: European Medicines Agency [last accessed 24 September 2020].
Grants and funding
LinkOut - more resources
Full Text Sources
